These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Nebulized salbutamol in life-threatening asthma: is IPPB necessary?
    Author: Fergusson RJ, Carmichael J, Rafferty P, Willey RF, Crompton GK, Grant IW.
    Journal: Br J Dis Chest; 1983 Jul; 77(3):255-61. PubMed ID: 6351888.
    Abstract:
    A double-blind crossover trial compared equal doses of nebulized salbutamol delivered with and without intermittent positive pressure breathing (IPPB) in 20 patients admitted to hospital with life-threatening asthma. No significant differences were observed between the two forms of treatment. It was concluded that the use of IPPB to administer nebulized salbutamol in oxygen had no advantage over passive inhalation in the initial treatment of patients with severe acute asthma.
    [Abstract] [Full Text] [Related] [New Search]